Skip to main content

RYTM

Stock
Health Care
Biotechnology

Performance overview

RYTM Price
Price Chart

Forward-looking statistics

Beta
0.95
Risk
49.18%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

rhythm pharmaceuticals inc. is a biotechnology company located in 855 boylston street, 11th floor, boston, ma, united states.

Company info

SectorHealth Care
IndustryBiotechnology
Employees212
Market cap$2.4B

Fundamentals

Enterprise value$4.0B
Revenue$136.9M
Revenue per employee—
Profit margin-123.28%
Debt to equity69.65

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$2.80
Dividend per share—
Revenue per share$2.22
Avg trading volume (30 day)$53M
Avg trading volume (10 day)$64M
Put-call ratio—

Macro factor sensitivity

Growth-1.1
Credit+7.0
Liquidity+1.5
Inflation-4.3
Commodities-1.2
Interest Rates-2.1

Valuation

Dividend yield0.00%
PEG Ratio-24.63
Price to sales30.57
P/E Ratio-24.63
Enterprise Value to Revenue28.96
Price to book220.70

Upcoming events

Next earnings dayMay 7, 2025
Next dividend day—
Ex. dividend day—

News

RYTM Stock Rises on Upbeat Acquired Hypothalamic Obesity Study Data

Rhythm Pharmaceuticals jumps 36.6% after its oral drug bivamelagon shows strong BMI and hunger reductions in a phase II study in acquired hypothalamic obesity.

Zacks Investment Research (July 10, 2025)
Stifel's Paul Matteis says look for biotech names not dependent on the FDA amid sector uncertainty

Paul Matteis, Stifel head of biotech research, joins 'The Exchange' to discuss the biotech trade under a new FDA amid the top vaccine official resigning.

CNBC Television (March 31, 2025)
Rhythm Pharmaceuticals' Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential

Oppenheimer initiated coverage on Rhythm Pharmaceuticals Inc. RYTM, a developer of treatment for rare obesity disorders.

Benzinga (December 20, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free